|
|
News Breaks | | | | November 27, 2012 | | 07:07 EDT |  | CBLI | Cleveland BioLabs subsidiary signs contract for about $4.6M with Russia
Cleveland BioLabs and Panacela Labs announced award of a contract valued at 146 million rubles, or approximately $4.6M with the Ministry of Industry and Trade of the Russian Federation for development of Xenomycins, a family of compounds in development as anti-infective agents. The contract, issued under the Russian Federation's "Pharma 2020" development initiative, provides matching funding over a period of approximately three years, which will be used to support preclinical and clinical studies. | |
|
News For CBLI From The Last 14 Days Check below for free stories on CBLI the last two weeks. |
|
|
| May 9, 2013 | | 07:50 EDT |  | CBLI | Cleveland BioLabs reports Q1 EPS (22c), one estimate (17c)
Reports Q1 revenue $1.37M, one estimate $1.73M. | |
|
|
|
|
|
|
